Eurofins Pharma Services newsletter N°4 - February 2013
ARTICLES:
- New state-of-the-art Competence Centre for metals testing in pharmaceuticals and biopharmaceuticals established in Copenhagen
- Adventitious virus testing via Next Generation Sequencing
- Evaluation of human skin absorption risk for pharmaceutical and cosmetic products: an in-vitro approach
- Critical aspects of antibody-drug conjugates: structure and analysis
- Logistics and full project management: a key for success in early clinical drug development
In brief:
- Quantification of residual DNA from production strains or cell lines in biopharmaceutical and biotechnological products (residual DNA testing)
- Coming events
> Download the pdf version of the newsletter
Receive the next newsletter via email
